A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

Gov. Jim Justice — and Babydog — came to Morgantown Monday for two ceremonial funding announcements: for WVU's Rockefeller Neuroscience Institute and for Mylan Park's KOA RV Resort and Campground ...

Well, that was fast. It took Gov. Jim Justice all of one day after winning a seat in the U.S. Senate to play an exclusive game of political nepotism, appointing ...

The patent office decision would allow Mylan immediately to return to the market across Europe ... enforcement in the ...

Viatris (VTRS) stock surges after Q3 earnings beat expectations with strong revenue growth and optimistic revenue outlook for ...

Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped ...

In trials, ultrasound treatments have been more directed and efficient than current treatments with IV drugs. “The first ...

Mylan has paid $96.5 million to settle claims it delayed launching a generic of narcolepsy drug Provigil in exchange for a payment from the originator, Cephalon. Reuters reported the settlement ...

Mylan CEO Heather Bresch said ... Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi it held earlier this year as uptake remains sluggish.

A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...

Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic ... telegraphing a restructuring initiative to prioritize the drug in heart failure—and in a potential future Type 1 diabetes ...

Heritage is ponying up $10 million while Apotex is set to pay $39.1 million over the companies’ alleged roles in a sweeping ...